Brainsway treatment sharply reduces smoking addiction

84% of smokers in a trial of the company's Deep TMS device stopped smoking.

Brainsway Ltd. (TASE:BRIN) today announced that a trial of its Deep TMS (transcranial magnetic stimulation) enabled smokers to give up cigarettes. 84% of the participants in the study who received frequent treatments gave up smoking at the end of the six-month course of treatment. 36% of the people were still not smoking after the six-month post treatment monitoring period.

The 115 participants in the study were divided into three groups: one group received a placebo, the second group received infrequent treatments, and the third group received frequent treatments. Half of the participants in each group first received a stimulant to temporarily increase the desire to smoke. 78 patients completed the study: 32 who received frequent treatments, 14 who received infrequent treatments and 32 who received the placebo. The infrequent treatments were terminated when the interim results showed that they were ineffective in stopping smoking.

Earlier this month, the US Food and Drug Administration (FDA) and Health Canada approved the Deep TMS device for the treatment of depression in patients who do not respond to drugs.

Published by Globes [online], Israel business news - - on January 24, 2013

© Copyright of Globes Publisher Itonut (1983) Ltd. 2013

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018